Edward J. Ludwig bought 5,000 shares of Boston Scientific Corp on the open market on July 31, 2026, paying $45.48 per share for a total outlay of about $227,400. Open-market purchases using personal funds tend to draw more attention than option-related transactions because they represent a direct decision to increase exposure at the current market price. Ludwig is listed as an insider, meaning he has access to internal information and is typically a senior leader, director, or other person with a meaningful connection to the company. While insiders can buy for many personal reasons, a purchase of this size is often viewed by investors as a vote of confidence in the business, particularly when it is not tied to a pre-arranged trading plan. Over the last 30 days, this filing is the only reported insider transaction at BSX, so there isn’t broader insider buying or selling activity to compare it with. That makes Ludwig’s trade a more prominent data point, but also means investors should treat it as a single signal rather than part of a larger trend across the leadership team.